Lúpus eritematoso sistêmico e gravidez

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that predominantly affects young women of unknown cause, is characterized by the presence of several autoantibodies. SLE occurs predominantly in women of reproductive age and is a risk for maternal and fetal complications, such as miscarriage, preeclampsia, worsening of disease, and others. Pregnancy is a big risk for the mother and the fetus, so it must be planned. For this to occur the disease should be stable for at least six months, it is important to monitor the patient before and throughout pregnancy to a better prognosis. However, pregnancy is contraindicated in a patient with lupus. This intends to conduct a literature review on the subject in order to treat SLE during pregnancy. In order to describe the clinical, diagnostic and therapeutic features of SLE in pregnancy.